CN Patent

CN116589451B — 一种6-氧杂螺[4,5]癸烷类化合物的新晶型、用途及其制备方法

Assigned to Chengdu Shuoder Pharmaceutical Co ltd · Expires 2024-07-09 · 2y expired

What this patent protects

本申请涉及药物晶型领域，具体涉及一种(R)‑2‑(9‑(4‑氟苯基)‑6‑氧杂螺[4,5]癸烷‑9‑基)‑N‑(2‑(吡啶‑4‑基)苄基)乙胺二盐酸盐晶型及其制备方法。本发明所得到的式(I)化合物的晶型具备优良的稳定性，并且所用结晶溶剂低毒低残留，适合于大规模生产放大。

USPTO Abstract

本申请涉及药物晶型领域，具体涉及一种(R)‑2‑(9‑(4‑氟苯基)‑6‑氧杂螺[4,5]癸烷‑9‑基)‑N‑(2‑(吡啶‑4‑基)苄基)乙胺二盐酸盐晶型及其制备方法。本发明所得到的式(I)化合物的晶型具备优良的稳定性，并且所用结晶溶剂低毒低残留，适合于大规模生产放大。

Drugs covered by this patent

Patent Metadata

Patent number
CN116589451B
Jurisdiction
CN
Classification
—
Expires
2024-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Shuoder Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.